The chart is not accessible to screen readers. Please switch to the table view to access the data.
Advertisement
Advertisement
Research and development expenditure of GW Pharmaceuticals from 2017 to 2020 (in million U.S. dollars)
R&D expenditure of GW Pharmaceuticals 2017-2020
In 2020, GW Pharmaceuticals spent around 205 million U.S. dollars on research and development, which is a significant increase from around 112 million U.S. dollars spent in 2017. This statistic illustrates the research and development expenditure of GW Pharmaceuticals worldwide from 2017 to 2020. In May 2021, the company was acquired by Ireland-based biopharma company Jazz Pharmaceuticals.
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Total operating expenses of GW Pharmaceuticals 2017-2020
- Basic Statistic Jazz Pharmaceuticals R&D expenditure 2016-2024
- Basic Statistic Net loss of GW Pharmaceuticals from 2017 to 2020
- Premium Statistic Total revenue of GW Pharmaceuticals 2017-2020
- Basic Statistic Total assets of GW Pharmaceuticals 2017-2020
- Basic Statistic Number of employees at GW Pharmaceuticals 2020, by geography
- Basic Statistic Total assets of Jazz Pharmaceuticals 2016-2024
- Premium Statistic Total revenue of Jazz Pharmaceuticals 2016-2024
- Basic Statistic Employees at Jazz Pharmaceuticals 2021-2024, by region
- Premium Statistic Medical cannabis market size in the United States 2023-2027
About the region
10
- Premium Statistic Jazz Pharmaceuticals top products sales 2022-2024
- Premium Statistic Sales forecast of major cannabis pharmaceutical products by world region 2023-2027
- Premium Statistic Sales forecast of major cannabis pharmaceutical products worldwide 2023-2027
- Basic Statistic Cannabis patents under Jazz Pharmaceuticals by patent family 2023
- Basic Statistic Share of cannabis clinical trials worldwide by sponsor 2010-2023
- Premium Statistic Cannabis patents under Jazz Pharmaceuticals' subsidiaries 2023
- Premium Statistic Leading MS pharmaceutical drugs in the U.S. by revenue 2013
- Basic Statistic 3 year average R&D cost to develop new biopharmaceutical compounds 2010-2020
- Basic Statistic Regenerative medicines market share by application forecast 2016 and 2025
- Basic Statistic Pharmaceutical sector expenditures worldwide forecast by country 2017
Selected statistics
10
- Premium Statistic Projected medical cannabis market size in Europe by country 2027
- Basic Statistic Medical cannabis patients Denmark 2023-2027
- Basic Statistic Spending and growth worldwide in oncology market 2025-2029
- Premium Statistic Leading therapy classes by spending global market 2028
- Premium Statistic Number of biopharmaceutical deals worldwide 2016-2020, by type
- Premium Statistic Revenue in the pharmaceuticals market in Italy 2016-2030
- Basic Statistic Pharmaceutical current R&D spending distribution in Canada by region 2020-2023
- Premium Statistic Bristol-Myers Squibb's ad and promo spending 2011-2024
- Basic Statistic U.S. investment for emerging therapeutic companies 2011-2023
- Basic Statistic Number of Canadian registered medical marijuana patients by quarter 2015-2024
Other regions
10
- Premium Statistic Distribution of medical cannabis oil exports Canada 2020, by importer
- Premium Statistic Medical cannabis market size forecast by U.S. state 2027
- Premium Statistic Medical cannabis market size in Europe by country 2023
- Premium Statistic Largest M&A deals in cannabis industry in North America 2021
- Basic Statistic Biosimilars in development and approved by FDA 2019, by manufacturer
- Premium Statistic Sales revenue Celltrion 2014-2024
- Premium Statistic Distribution of Celltrion's revenue Q3 2024, by product
- Basic Statistic Spending on direct-to-consumer drug advertising in the U.S. 2016-2018, by media type
- Basic Statistic Medical cannabis patients Canada 2023-2027
- Premium Statistic Distribution of Celltrion's bioproduct revenue Q3 2024
Related statistics
10
- Basic Statistic Regenerative medicines market size forecast 2025
- Premium Statistic Outsourced research penetration in pharmaceutical industry worldwide 2011-2020
- Basic Statistic Regenerative medicines market size by therapy type forecast 2016-2025
- Basic Statistic Spending change on branded and generic medicines in the U.S. 2014-2021
- Basic Statistic R&D cost to develop new pharmaceutical compounds 2010-2020
- Premium Statistic Biosimilars approved for marketing Europe vs U.S. 2022 by year since approval
- Basic Statistic Gen-Z share of cannabis sales in U.S. states by quarter 2020-2021
- Premium Statistic Market share of generics in Finland 2016-2021
- Basic Statistic Share of cannabis clinical trials worldwide by intervention 2010-2023
- Premium Statistic Market value of CBD in Latin America 2023, by country
Further Content: You might find this interesting as well
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
GW Pharmaceuticals. (February 26, 2021). Research and development expenditure of GW Pharmaceuticals from 2017 to 2020 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 27, 2026, from /statistics/1264924/research-and-development-expenditure-of-gw-pharmaceuticals/
GW Pharmaceuticals. "Research and development expenditure of GW Pharmaceuticals from 2017 to 2020 (in million U.S. dollars) ." Chart. February 26, 2021. ÌÇÐÄÆƽâ°æ. Accessed July 27, 2026. /statistics/1264924/research-and-development-expenditure-of-gw-pharmaceuticals/
GW Pharmaceuticals. (2021). Research and development expenditure of GW Pharmaceuticals from 2017 to 2020 (in million U.S. dollars) . ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 27, 2026. /statistics/1264924/research-and-development-expenditure-of-gw-pharmaceuticals/
GW Pharmaceuticals. "Research and Development Expenditure of Gw Pharmaceuticals from 2017 to 2020 (in Million U.S. Dollars) ." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 26 Feb 2021, /statistics/1264924/research-and-development-expenditure-of-gw-pharmaceuticals/
GW Pharmaceuticals, Research and development expenditure of GW Pharmaceuticals from 2017 to 2020 (in million U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/1264924/research-and-development-expenditure-of-gw-pharmaceuticals/ (last visited July 27, 2026)
Research and development expenditure of GW Pharmaceuticals from 2017 to 2020 (in million U.S. dollars) [Graph], GW Pharmaceuticals, February 26, 2021. [Online]. Available: /statistics/1264924/research-and-development-expenditure-of-gw-pharmaceuticals/
Advertisement